Komori
Governance4582SymBio Pharmaceuticals LimitedPharmaceuticals

Independent Officer Notification Form

Nomura Hiroshi (野村博), who was an outside director and independent officer, resigned effective 31 July 2026, so the details reported for independent officers were updated. The filing lists Shimomura Koichi (下村恒一) as the sole independent officer.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Number of directors6 outside directors (including 1 independent officer)
Number of independent officers1Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

As Nomura Hiroshi (野村博), an outside director and independent officer, resigned effective 31 July 2026, an Independent Officer Notification Form was filed. All persons meeting the eligibility requirements for independent officers have been designated as independent officers.

Governance structure
ItemDetails
Number of directors6 outside directors (including 1 independent officer)
Number of independent officers1
Changes this timeAs Nomura Hiroshi (野村博), an outside director and independent officer, resigned effective 31 July 2026, an Independent Officer Notification Form was filed. All persons meeting the eligibility requirements for independent officers have been designated as independent officers.
Items this document does not state (5)
Corporate Governance StructureCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because Nomura Hiroshi (野村博), an outside director and independent officer, resigned effective 31 July.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | SymBio Pharmaceuticals Limited (4582) timely disclosure | Komori